Pediatric Studies Become Costlier; Congress May Make Them Less Profitable
Executive Summary
Drug companies are spending eight times more money to carry out a pediatric study than they were six years ago, Tufts University researchers found in a recent industry survey
You may also be interested in...
Permanent Pediatric Research Laws Would Spur In-House Units – J&J Exec
Enacting a permanent authorization for federal pediatric research programs would encourage pharmaceutical companies to create dedicated pediatric research programs within their operations, a Johnson & Johnson executive suggested to the Senate Health, Labor and Pensions Committee March 27
Permanent Pediatric Research Laws Would Spur In-House Units – J&J Exec
Enacting a permanent authorization for federal pediatric research programs would encourage pharmaceutical companies to create dedicated pediatric research programs within their operations, a Johnson & Johnson executive suggested to the Senate Health, Labor and Pensions Committee March 27
Pediatric Exclusivity May Overcompensate Blockbuster Products – JAMA Study
The net economic return to companies granted pediatric exclusivity ranged from $8.9 million to $507 million, researchers found in a study of the economic impact of the pediatric exclusivity program